✦ LIBER ✦

Are Tyrosine Kinase Inhibitors Still Active in Patients With Metastatic Renal Cell Carcinoma Previously Treated With a Tyrosine Kinase Inhibitor and Everolimus? Experience of 36 Patients Treated in France in the RECORD-1 Trial

✍ Scribed by Blesius, Aurore; Beuselinck, Benoit; Chevreau, Christine; Ravaud, Alain; Rolland, Frédéric; Oudard, Stéphane; Escudier, Bernard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of Single-Agent Bevacizumab in

✍ Turnbull, James D.; Cobert, Julien; Jaffe, Tracy; Harrison, Michael R.; George, 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 345 KB

Levels of circulating CD45dimCD34+VEGFR2

✍ Farace, F; Gross-Goupil, M; Tournay, E; Taylor, M; Vimond, N; Jacques, N; Billio 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 423 KB

High Frequency of Intracerebral Hemorrha

✍ Damien Pouessel; Stéphane Culine 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Everolimus in metastatic renal cell carc

✍ E. Calvo; B. Escudier; R.J. Motzer; S. Oudard; T.E. Hutson; C. Porta; S. Bracard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Overall survival in patients with metast

✍ Sergio Bracarda; Joaquim Bellmunt; Bohuslav Melichar; Sylvie Négrier; Emilio Baj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

A phase 1b clinical trial of the multi-t

✍ Molina, Ana M.; Hutson, Thomas E.; Larkin, James; Gold, Anne M.; Wood, Karen; Ca 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 395 KB